TickerFacts.

Niki BioSolutions, Inc. (NIKI): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$420.8K
Year ended 2023-12-31
$1.46M2021-12-31: $1.46M2022-12-31: $1.22M2023-12-31: $420.8K$420.8K
2021-12-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$420.8K-65.4%2026-03-27, From 2023-01-01
2022-12-31$1.22M-16.7%2025-04-30, From 2022-01-01
2021-12-31$1.46Mn/a2024-04-30, From 2021-01-01